ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 98 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.21 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $40,376,000 | +39.9% | 1,143,790 | 0.0% | 0.51% | +64.8% |
| Q4 2020 | $28,869,000 | -33.1% | 1,143,790 | 0.0% | 0.31% | -50.8% |
| Q3 2020 | $43,132,000 | -34.8% | 1,143,790 | -25.9% | 0.63% | -41.2% |
| Q2 2020 | $66,105,000 | +120.3% | 1,543,790 | 0.0% | 1.07% | +37.0% |
| Q1 2020 | $30,011,000 | -25.2% | 1,543,790 | 0.0% | 0.78% | -1.9% |
| Q4 2019 | $40,107,000 | -4.7% | 1,543,790 | 0.0% | 0.80% | -29.7% |
| Q3 2019 | $42,075,000 | +1.5% | 1,543,790 | 0.0% | 1.13% | +19.2% |
| Q2 2019 | $41,450,000 | -7.1% | 1,543,790 | 0.0% | 0.95% | -24.5% |
| Q1 2019 | $44,630,000 | +7.4% | 1,543,790 | 0.0% | 1.26% | -20.4% |
| Q4 2018 | $41,574,000 | – | 1,543,790 | – | 1.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $16,381,000 | 9.53% |
| Wildcat Capital Management, LLC | 2,128,370 | $19,389,000 | 4.96% |
| TPG GP A, LLC | 18,716,306 | $170,506,000 | 2.11% |
| Pier Capital, LLC | 746,669 | $6,802,000 | 0.87% |
| Coastal Bridge Advisors, LLC | 401,929 | $3,662,000 | 0.84% |
| HARBOR CAPITAL ADVISORS, INC. | 92,755 | $845,000 | 0.40% |
| Lombard Odier Asset Management (Switzerland) SA | 501,219 | $4,566,000 | 0.36% |
| Navalign, LLC | 74,271 | $623,000 | 0.26% |
| PDT Partners, LLC | 241,592 | $2,201,000 | 0.19% |
| GSA CAPITAL PARTNERS LLP | 148,804 | $1,356,000 | 0.18% |